Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
deals
3
×
life sciences
national blog main
boston top stories
clinical trials
fda
investing
san francisco blog main
startups
480 biomedical
akouos
arsenal medical
astellas pharmaceuticals
azacitidine
beta-thalassemia
bob langer
california institute for biomedical research
chronic rhinosinusitis
covid-19
dacogen
decibel therapeutics
decitabine
dna
drug delivery
epigenetics
epizyme
farydak
flagship pioneering
frequency therapeutics
fulcrum therapeutics
genzyme
george whitesides
harvard university
hearing loss
inflammation
insulated genomic domains
ipo
What
developing
3
×
therapeutics
biotech
ipo
medicines
new
treat
affects
aims
americans
approach
approved
based
called
company
date
debut
debuts
drug
drugs
epigenetic
epigenetics
fda
field
flagship’s
frequency
hearing
late
loss
lyra
markets
meds
million
millions
morning
nose
noses
omega
persistently
plans
Language
unset
3
×
Current search:
deals
×
developing
×
unset
×
@xconomy.com
3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds